Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42.1M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
+8.67M
-
Total reported value, excl. options
-
$54.8M
-
Value change
-
+$20.9M
-
Number of buys
-
24
-
Number of sells
-
-8
-
Price
-
$2.41
Significant Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q3 2025
45 filings reported holding NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value as of Q3 2025.
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 42.1M outstanding shares and own 54.02% of the company stock.
Largest 10 shareholders include Rosalind Advisors, Inc. (3.91M shares), Nantahala Capital Management, LLC (3.38M shares), Aberdeen Group plc (2.48M shares), Parkman Healthcare Partners LLC (2.44M shares), Velan Capital Investment Management LP (2.14M shares), ORBIMED ADVISORS LLC (2.13M shares), MARSHALL WACE, LLP (1.86M shares), Soleus Capital Management, L.P. (1.47M shares), Ghisallo Capital Management LLC (922K shares), and PURA VIDA INVESTMENTS, LLC (451K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.